What is missing There is no published human pharmacokinetic study of subcutaneous AOD-9604, no published human topical or intranasal exposure data, no Phase 3 efficacy trial, no long-term safety data beyond 24 weeks, and no published human cartilage or joint outcome data
State Reconstituted (from powder) Storage 35.6-46.4F (2-8C) Notes Typical 14-30 day window depending on compounder guidance
Because the natural environment is complex, it is challenging to fully recaptiulate
To our knowledge, only one study has been conducted among PD patients linking Vit B12 role, the methylation status and the neurodegenerative markers of PD including SN (Obeid et al
However, it can also be linked to underlying inflammation, poor biomechanics, or systemic factors that reduce tissue recovery